Booking chair plans $198K stock sale in 2026

Booking Holdings Inc. (BKNG) is named as the issuer in a Form 144 notice covering a planned resale of common stock associated with director and chairman Robert J. Mylod Jr.

Rhea-AI Filing Summary

Booking Holdings Inc. (BKNG) is named as the issuer in a Form 144 notice covering a planned resale of common stock associated with director and chairman Robert J. Mylod Jr. UBS Financial Services Inc. is listed as the broker for the transaction, acting as attorney-in-fact for Mylod.

The notice indicates that 1,000 shares of Booking Holdings common stock, originally granted on 09/01/2022, are planned to be sold on or after 09/01/2026 with an indicated aggregate value of $198,400. A remark states that the shares covered by this filing are being sold by Annox Capital LLC, an entity associated with Mylod. Over the prior three months, Annox Capital LLC reported additional Rule 144 sales of Booking Holdings common stock.

Key Figures

Planned shares to be sold: 1,000 shares of common stock Aggregate value of planned sale: $198,400.00 Past sale on 07/29/2026: 5,000 shares for $1,000,000.00 +2 more

5 metrics

Planned shares to be sold 1,000 shares of common stock Planned Rule 144 sale associated with Robert J. Mylod Jr.

Aggregate value of planned sale $198,400.00 Indicated aggregate value for 1,000 shares to be sold on or after 09/01/2026

Past sale on 07/29/2026 5,000 shares for $1,000,000.00 Rule 144 sale by Annox Capital LLC during the past 3 months

Past sale on 08/05/2026 1,000 shares for $206,700.00 Rule 144 sale by Annox Capital LLC during the past 3 months

Grant date of shares 09/01/2022 Grant made to director for the 1,000 shares covered by the planned sale

Key Terms

Rule 144, Form 144, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

attorney-in-fact regulatory

"UBS Financial Services Inc., as attorney-in-fact for Robert J. Mylod Jr."

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does BKNG's Form 144 filed for Robert J. Mylod Jr. disclose?

It discloses a planned sale under Rule 144 of 1,000 shares of Booking Holdings Inc. common stock associated with Robert J. Mylod Jr., with UBS Financial Services Inc. acting as attorney-in-fact and broker, and notes that the shares are being sold by Annox Capital LLC.

How many BKNG shares are planned to be sold under this Form 144 notice?

The notice covers a planned sale of 1,000 shares of Booking Holdings Inc. common stock, with an indicated aggregate value of $198,400, and a proposed sale date of 09/01/2026.

Who is the person on whose behalf BKNG shares are being sold in this Form 144?

The person is Robert J. Mylod Jr., identified as chairman and director of Booking Holdings Inc. A remark states that the shares covered by the filing are being sold by Annox Capital LLC, with UBS Financial Services Inc. acting as attorney-in-fact.

What prior BKNG stock sales are reported for the past 3 months in the Form 144?

Annox Capital LLC is reported to have sold 5,000 shares of Booking Holdings common stock for $1,000,000.00 on 07/29/2026 and 1,000 shares for $206,700.00 on 08/05/2026 under Rule 144 aggregation rules.

Which broker is handling the planned BKNG share sale under this Form 144?

The broker listed is UBS Financial Services Inc., with an address at Eleven Madison Avenue, New York, New York. UBS is identified as acting as attorney-in-fact for Robert J. Mylod Jr. in connection with the planned Rule 144 sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 04:08 PM Accepted by SEC EDGAR 09/01/2026 - 04:06 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001214607
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Booking Holdings Inc.
SEC File Number	001-36691
Address of Issuer	800 CONNECTICUT AVE NORWALK CONNECTICUT 06854
Phone	203-299-8000
Name of Person for Whose Account the Securities are To Be Sold	MYLOD ROBERT J JR
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chairman

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	1000	198400.00	751380500	09/01/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2022	Grant made to Director	Issuer			1000	09/01/2022	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Annox Capital LLC 800 CONNECTICUT AVE Norwalk CT 06854	Common	07/29/2026	5000	1000000.00
Annox Capital LLC 800 CONNECTICUT AVE Norwalk CT 06854	Common	08/05/2026	1000	206700.00

144: Remarks and Signature

Remarks	The shares covered by this filing are being sold by Annox Capital LLC.
Date of Notice	09/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc., as attorney-in-fact for Robert J. Mylod Jr.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)